Suppr超能文献

丝素蛋白具有较强的水合能力,可抑制冷冻保存过程中冰晶的形成和重结晶。

Strong Hydration Ability of Silk Fibroin Suppresses Formation and Recrystallization of Ice Crystals During Cryopreservation.

机构信息

Key Laboratory of Green Printing, Beijing National Laboratory for Molecular Science, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.

CAS Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.

出版信息

Biomacromolecules. 2022 Feb 14;23(2):478-486. doi: 10.1021/acs.biomac.1c00700. Epub 2021 Aug 11.

Abstract

The cryopreservation (CP) of cell/tissue is indispensable in medical science. However, the formation of ice during cooling and ice recrystallization/growth in time of thawing present significant risk of cell/tissue damage upon analysis of CP process. Herein, the natural and biocompatible silk fibroin (SF) with regular hydrophobic and hydrophilic domains, were first employed as a cryoprotectant (CPA), to the CP of human bone-derived mesenchymal stem cells (hBMSCs), which has been routinely cyropreserved for cell-based therapies. Addtion of SF can regulate the formation of ice crystals during cooling process because of its strong hydration ability in the comparation to the cryopreservation medium (CM) without SF. Moreover, the devitrification-induced recrystallization/growth of ice during the thawing process is suppressed. Most importantly, the addition of 10 mg mL SF can achieve 81.28% cell viability of cryopreserved hBMSCs as similar as those with the addition of 180 mg mL Ficoll 70 (commercial CPA), and the functions of the cryopreserved hBMSCs are maintained as good as that of the fresh ones. This work is not only significant for meeting the ever-increasing demand of cell therapy, but also trailblazing for designing materials in controlling ice formation and growth during the CP of other cells and tissues.

摘要

细胞/组织的低温保存(CP)在医学中是不可或缺的。然而,在冷却过程中形成冰以及在解冻过程中冰再结晶/生长会对细胞/组织造成严重的损伤。在此,天然且生物相容性的丝素蛋白(SF),具有规则的疏水和亲水区域,首次被用作保护剂(CPA),用于低温保存人类骨髓间充质干细胞(hBMSCs),这是细胞治疗中常规的低温保存方法。与不含 SF 的低温保存介质(CM)相比,SF 强大的水合能力可以调节冷却过程中冰晶的形成。此外,还抑制了解冻过程中玻璃态转化诱导的冰再结晶/生长。最重要的是,添加 10mg/mL SF 可以实现 81.28%的低温保存 hBMSCs 存活率,与添加 180mg/mL Ficoll 70(商业性的 CPA)相似,且低温保存 hBMSCs 的功能与新鲜细胞相似。这项工作不仅对满足日益增长的细胞治疗需求具有重要意义,而且为设计控制其他细胞和组织低温保存过程中冰形成和生长的材料提供了新的思路。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验